New approach aims to keep shoulder moving after surgery
NCT ID NCT06587386
Summary
This study tested different doses of a long-acting numbing medicine (liposomal bupivacaine) for patients having shoulder surgery. The goal was to find the lowest dose that effectively controls pain for up to 72 hours while still allowing patients to move their arm. Researchers worked with 55 adults to determine which dose best balanced pain relief with preserved muscle function.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MOTION SICKNESS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Affiliated Hospital of Jiaxing University
Jiaxing, China
Conditions
Explore the condition pages connected to this study.